In a recent Bloomberg News article, according to US regulators Perrigo failed to protect consumers from ibuprofen tablets contaminated with metal shavings, four years after the company recalled similarly tainted acetaminophen pills.
Perrigo was forced to pull the ibuprofen from the market after the tablets were released by its Allegan, Michigan, plant, according to an April 29 warning letter sent outby the Food and Drug Administration" on Tuesday.
According to the FDA, Perrigo "failed to thoroughly investigate why some tablets were the wrong size and didn't inspect packaging equipment between batches."
The warning follows Perrigo’s 2006 recall of 11 million bottles of acetaminophen pills containing pieces of wire as long as 8 millimeters (0.32 inches). The FDA ordered the company to fix its quality-control issues or face product seizure, injunction or a ban on exports or new product approvals.
Perrigo is the world’s largest maker of non-prescription, store branded drugs.
To read the Bloomberg News report, visit: http://www.bloomberg.com/apps/news?pid=newsarchive&sid=aEYk_t22lj18.
Secure Pharma Chain blog, endorses that all members of the pharmaceutical supply chain utilize authentication technologies to verify the authenticity and quality of their inventories and protect the consumer from fraudulent, adulterated and counterfeit materials.
To learn more about supply chain authentication solutions, visit: http://www.xstreamsystems.net/.
No comments:
Post a Comment